Leprosy Mailing List, June 30th, 2008
Ref.: Leprosy and leishmaniasis
From: Bryceson A., London, UK
Dear Salvatore,
I refer to Dr Villarreal’s messages. It is an interesting case. Ross Barnetson and I published eight cases of leprosy plus leishmaniasis from Ethiopia in 1978, so the coincidence might not be so rare in Bolivia, despite the lack of reported cases.
Barnetson RS, Bryceson AD. Cutaneous leishmaniasis and leprosy. Trans R Soc Trop Med Hyg. 1978;72:160-163.
Best wishes
Anthony
Showing posts with label Leishmaniasis. Show all posts
Showing posts with label Leishmaniasis. Show all posts
Monday, June 30, 2008
Leprosy and Leishmaniasis; thank you!
Leprosy Mailing List, June 29th, 2008
Ref.: Leprosy and Leishmaniasis; thank you!
From: Villarreal Olaya M. E., La Paz, Bolivia
Dear Dr. Noto
I would like to thank all the people that have written me on the case of leprosy and Leishmaniasis. It is the first case reported in my country with this association.
Thanks to all.
Dr (Ms) Villarreal
Ref.: Leprosy and Leishmaniasis; thank you!
From: Villarreal Olaya M. E., La Paz, Bolivia
Dear Dr. Noto
I would like to thank all the people that have written me on the case of leprosy and Leishmaniasis. It is the first case reported in my country with this association.
Thanks to all.
Dr (Ms) Villarreal
Leprosy and Leishmaniasis
Leprosy Mailing List, June 27th, 2008
Ref.: Leprosy and Leishmaniasis
From: Dahiru T., Rayfield, Plateau State, Nigeria
Dear Salvatore,
I refer to Dr Villarreal’s LML message dated June 25th, 2008. The two diseases, leprosy and Leishmaniasis, can be treated concurrently with minimal risk of drug interaction. Careful monoring of this patient for possible severe type 2 reaction is recommended.
Greetings,
Tahir
Medical Adviser to the Netherlands Leprosy Relief
Rayfield, Plateau State
Nigeria
Ref.: Leprosy and Leishmaniasis
From: Dahiru T., Rayfield, Plateau State, Nigeria
Dear Salvatore,
I refer to Dr Villarreal’s LML message dated June 25th, 2008. The two diseases, leprosy and Leishmaniasis, can be treated concurrently with minimal risk of drug interaction. Careful monoring of this patient for possible severe type 2 reaction is recommended.
Greetings,
Tahir
Medical Adviser to the Netherlands Leprosy Relief
Rayfield, Plateau State
Nigeria
Leprosy and Leishmaniasis
Leprosy Mailing List, June 26th, 2008
Ref.: Leprosy and Leishmaniasis
From: Villarreal Olaya M. E., La Paz, Bolivia
Dear Dr. Noto,
I would like to thank very much the Authors of the comments I have already received.
Herewith are the information requested by Prof. William Faber:-
1.
The previous treatment was at the time the patient had cutaneous leismaniasis.
2.
The cutaneous leismaniasis is cured, but he has now a mucocutaneous leismaniasis with spread to orofarigeal mucous membrane. He needs treatment with Anfotericina B for 2 months, and I would like to know if I can administer both Anfotericina and MDT for leprosy without to have adverse effects or begin with Anfotericina.
3.
The patient received the treatment 5 years ago and we do not know what dosage of Glucantime he received.
Thanks a lot for your attention.
Dr (Ms) Villarreal
Ref.: Leprosy and Leishmaniasis
From: Villarreal Olaya M. E., La Paz, Bolivia
Dear Dr. Noto,
I would like to thank very much the Authors of the comments I have already received.
Herewith are the information requested by Prof. William Faber:-
1.
The previous treatment was at the time the patient had cutaneous leismaniasis.
2.
The cutaneous leismaniasis is cured, but he has now a mucocutaneous leismaniasis with spread to orofarigeal mucous membrane. He needs treatment with Anfotericina B for 2 months, and I would like to know if I can administer both Anfotericina and MDT for leprosy without to have adverse effects or begin with Anfotericina.
3.
The patient received the treatment 5 years ago and we do not know what dosage of Glucantime he received.
Thanks a lot for your attention.
Dr (Ms) Villarreal
Leprosy and mucocutaneous Leishmaniasis
Leprosy Mailing List, June 26th, 2008
Ref.: Leprosy and mucocutaneous Leishmaniasis
From: Faber W. R., Amsterdam, The Netherlands
ref.: Dr Villarreal’s message (LML June 25th, 2008)
Dear Dr Villarreal,
Before replying to your question I would like to have some additional information:-1: the previous leishmaniasis treatment was at that time with the diagnosis cutaneous or mucocutaneous leishmaniasis?
2: is his leishmaniasis at the moment cured? or does he need again treatment?
3: what dosage of glucantime was given: 20 mg/kg/day?
Greetings,William R Faber
Ref.: Leprosy and mucocutaneous Leishmaniasis
From: Faber W. R., Amsterdam, The Netherlands
ref.: Dr Villarreal’s message (LML June 25th, 2008)
Dear Dr Villarreal,
Before replying to your question I would like to have some additional information:-1: the previous leishmaniasis treatment was at that time with the diagnosis cutaneous or mucocutaneous leishmaniasis?
2: is his leishmaniasis at the moment cured? or does he need again treatment?
3: what dosage of glucantime was given: 20 mg/kg/day?
Greetings,William R Faber
Leprosy and mucocutaneous Leishmaniasis
Leprosy Mailing List, June 26th, 2008
Ref.: Leprosy and mucocutaneous Leishmaniasis
From: Naafs B., Munnekeburen, The Netherlands
ref.: Dr Villarreal’s message (LML June 25th, 2008)
Dear colleague,
My experience is from Ethiopia, long ago. I do not think that it is important, which treatment you start first. There is hardly any interaction. The only small risk is that treating the Leishmaniasis leads to an ENL reaction. But that may happen before and after the treatment for the leprosy has started.
With kind regards,
Dr Ben Naafs
Ref.: Leprosy and mucocutaneous Leishmaniasis
From: Naafs B., Munnekeburen, The Netherlands
ref.: Dr Villarreal’s message (LML June 25th, 2008)
Dear colleague,
My experience is from Ethiopia, long ago. I do not think that it is important, which treatment you start first. There is hardly any interaction. The only small risk is that treating the Leishmaniasis leads to an ENL reaction. But that may happen before and after the treatment for the leprosy has started.
With kind regards,
Dr Ben Naafs
Leprosy and mucocutaneous Leishmaniasis
Leprosy Mailing List, June 26th, 2008
Ref.: Leprosy and mucocutaneous Leishmaniasis
From: Talhari S., Manaus, Amazonas, Brazil
Dear Salvatore,
Regarding Dr Villarreal’s message (LML June 25th, 2008) about the treatment of Leishmaniasis + leprosy I suggest to repeat the treatment with antimonial and if there is no response - anphotericin or miltefosine.
Treatment of leprosy: - the same as recommended for multibacillary patients. It would be interesting to do an HIV test.
Best regards,
Sinésio Talhari
Institute of Tropical Medicine
Manaus, Amazonas, Brazil
Ref.: Leprosy and mucocutaneous Leishmaniasis
From: Talhari S., Manaus, Amazonas, Brazil
Dear Salvatore,
Regarding Dr Villarreal’s message (LML June 25th, 2008) about the treatment of Leishmaniasis + leprosy I suggest to repeat the treatment with antimonial and if there is no response - anphotericin or miltefosine.
Treatment of leprosy: - the same as recommended for multibacillary patients. It would be interesting to do an HIV test.
Best regards,
Sinésio Talhari
Institute of Tropical Medicine
Manaus, Amazonas, Brazil
Leprosy and mucocutaneous Leishmaniasis
Leprosy Mailing List, June 25th, 2008
Ref.: Leprosy and mucocutaneous Leishmaniasis
From: Villarreal Olaya M. E., La Paz, Bolivia
Dear Dr. Noto,
I have a 33 years old patient with multibacillary (MB) leprosy. His bacteriological index (BI) is 3+ and disability grade 2. He has also mucocutáneus Leishmaniasis with nose involvement. Five years ago he received Glucantime for 20 days.
I would really appreciate comments and suggestions from people with more experience. For e.g. what treatment do I begin first?
Thank you very much. Dra. M. E. Villarreal O.
La Paz
Bolivia
Ref.: Leprosy and mucocutaneous Leishmaniasis
From: Villarreal Olaya M. E., La Paz, Bolivia
Dear Dr. Noto,
I have a 33 years old patient with multibacillary (MB) leprosy. His bacteriological index (BI) is 3+ and disability grade 2. He has also mucocutáneus Leishmaniasis with nose involvement. Five years ago he received Glucantime for 20 days.
I would really appreciate comments and suggestions from people with more experience. For e.g. what treatment do I begin first?
Thank you very much. Dra. M. E. Villarreal O.
La Paz
Bolivia
Subscribe to:
Posts (Atom)